Thyrosafe
NDC Package 66983-350-20
Package Information
Thyrosafe is use helps prevent radioactive iodine from getting into the thyroid gland during a nuclear radiation emergency. Marketed by Recipharm Ab (publ), this product is identified by NDC 66983-350 and is authorized under FDA application ANDA076350.
Identification & Billing
- RxCUI: 1086474 - ThyroSafe 65 MG Oral Tablet
- RxCUI: 1086474 - potassium iodide 65 MG Oral Tablet [ThyroSafe]
- RxCUI: 1086474 - K+ Iodide 65 MG Oral Tablet [ThyroSafe]
- RxCUI: 1086474 - Pot Iodide 65 MG Oral Tablet [ThyroSafe]
- RxCUI: 430174 - potassium iodide 65 MG Oral Tablet
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 66983 - Recipharm Ab (publ)
- 66983-350 - Thyrosafe
- 66983-350-20 - 160 BOX in 1 CARTON / 20 BLISTER PACK in 1 BOX / 1 TABLET in 1 BLISTER PACK
- 66983-350 - Thyrosafe
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 66983-350-20 identifies a specific commercial package of 160 box in 1 carton / 20 blister pack in 1 box / 1 tablet in 1 blister pack of Thyrosafe, labeled by Recipharm Ab (publ). This product is billed for "EA" each discreet unit and contains an estimated amount of 160 billable units per package. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Recipharm Ab (publ) on September 30, 2002. The current certification is valid through December 31, 2022.
How is this Recipharm Ab (publ) product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 66983035020. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 160 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.